Inhibition of CD24 Expression Enhances the Anti-Melanoma Effect of Endostatin by Ameliorating Anti-Tumor Immune Responses in Melanoma-Bearing Mice

Authors

Institutions

Publication Details

Journal
Current Cancer Drug Targets
Published
2026-01-12
DOI
https://doi.org/10.2174/0115680096419727251121103534
Primary Topic
Angiogenesis and VEGF in Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inhibition of CD24 Expression Enhances the Anti-Melanoma Effect of Endostatin by Ameliorating Anti-Tumor Immune Responses in Melanoma-Bearing Mice

Tiesuo Zhao, Fang Lu, Meihua Fan, Yuhao Cao et al.
Current Cancer Drug Targets
Angiogenesis and VEGF in Cancer
article

Inhibition of CD24 Expression Enhances the Anti-Melanoma Effect of Endostatin by Ameliorating Anti-Tumor Immune Responses in Melanoma-Bearing Mice

Tiesuo Zhao, Fang Lu, Meihua Fan, Yuhao Cao, Wufan Zu, Ming Wang, Mengyu Lei, Ai Cui, Huijie Jia, Mingyao Li, Zhiang Liu, Chaohong Deng, Sheng Guo
article en

Abstract

No abstract available for this paper.
Current Cancer Drug TargetsVol. 26
Shantou University (CN), Second Affiliated Hospital of Shantou University Medical College (CN), Henan Medical University (CN)
Good health and well-being
Openalex Percentile: Top 79%
Angiogenesis and VEGF in Cancer
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.